Detailansicht

Wissensnetz

Person

Simone Susser (1977-)

Name	Simone Susser
Zeit	1977- (Lebensdaten)
Ort	Ludwigshafen am Rhein (Geburtsort) Deutschland
Weitere Angaben	Diss. Naturwissenschaften (Virologie), Universität Saarbrücken, Fakultät 2 - Medizin
Datensatztyp	Person
GND-Nummer	142300985
Datensatz-ID	142300985
Beteiligt an alle anzeigen Consideration of viral resistance for optimization of direct antiviral therapy of hepatitis C virus genotype 1-infected patients Performance and value of IFN-lambda3 and IFN-lambda4 genotyping in patients with chronic hepatitis C (CHC) genotype 2/3 in a real world setting Performance of two HCV RNA assays during protease inhibitor-based triple therapy in patients with advanced liver fibrosis and cirrhosis Predictive value of interferon-lambda gene polymorphisms for treatment response in chronic hepatitis C Vitamin D levels vary during antiviral treatment but are unable to predict treatment outcome in HCV genotype 1 infected patients Association of IFNL3 rs12979860 and rs8099917 with biochemical predictors of interferon responsiveness in chronic hepatitis C virus infection A common HLA-DPA1 variant is associated with hepatitis B virus infection but fails to distinguish active from inactive Caucasian carriers Soluble serum CD81 is elevated in patients with chronic hepatitis C and correlates with alanine aminotransferase serum activity Serum microRNA-21 as marker for necroinflammation in hepatitis C patients with and without hepatocellular carcinoma Genotypische und phänotypische Untersuchungen zu Resistenzmechanismen des Hepatitis-C-Virus gegenüber NS3-Protease-Inhibitoren

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Simone Susser (1977-)

Consideration of viral resistance for optimization of direct antiviral therapy of hepatitis C virus genotype 1-infected patients

Performance and value of IFN-lambda3 and IFN-lambda4 genotyping in patients with chronic hepatitis C (CHC) genotype 2/3 in a real world setting

Performance of two HCV RNA assays during protease inhibitor-based triple therapy in patients with advanced liver fibrosis and cirrhosis

Predictive value of interferon-lambda gene polymorphisms for treatment response in chronic hepatitis C

Vitamin D levels vary during antiviral treatment but are unable to predict treatment outcome in HCV genotype 1 infected patients

Association of IFNL3 rs12979860 and rs8099917 with biochemical predictors of interferon responsiveness in chronic hepatitis C virus infection

A common HLA-DPA1 variant is associated with hepatitis B virus infection but fails to distinguish active from inactive Caucasian carriers

Soluble serum CD81 is elevated in patients with chronic hepatitis C and correlates with alanine aminotransferase serum activity

Serum microRNA-21 as marker for necroinflammation in hepatitis C patients with and without hepatocellular carcinoma

Genotypische und phänotypische Untersuchungen zu Resistenzmechanismen des Hepatitis-C-Virus gegenüber NS3-Protease-Inhibitoren